TRANSDERMAL FORMULATIONS FOR DELIVERY OF CELECOXIB AND ITS USE IN THE TREATMENT OF CELECOXIB-RESPONSIVE DISEASES AND CONDITIONS

摘要

The present application is directed to transdermal formulations for the delivery of celecoxib to a subject for the treatment of celecoxib-responsive diseases or conditions. In particular, the transdermal formulation is an emulsion comprising an oil phase, an aqueous phase and an external phase.